Frontlight ResearchEarly access
Trial site
MVZ im Altstadt-Carree Fulda GmbH
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Obesity7 trials
- Type 2 diabetes6 trials
- Heart failure3 trials
- Chronic kidney disease2 trials
- Coronary artery disease1 trial
- Irritable bowel syndrome1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 312 trials
- Phase 42 trials
- Status
- Completed5 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Novo Nordisk A/S4 trials
- AstraZeneca2 trials
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- Amgen1 trial
- and 3 more
Running trials
Not yet recruiting
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Irritable bowel syndrome1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026